Previous 10 | Next 10 |
Nevro to Present at BofA Securities 2021 Virtual Health Care Conference Tuesday, May 11, 2021, at 2:00 pm Eastern Time / 11:00 am Pacific Time PR Newswire REDWOOD CITY, Calif. , April 13, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medic...
Nevro to Report First Quarter 2021 Financial Results Company to Host Conference Call on Wednesday, May 5, 2021, at 1:30 pm PT / 4:30 pm ET PR Newswire REDWOOD CITY, Calif. , April 7, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical dev...
Painful diabetic neuropathy [PDN] is a condition that affects ~30% of diabetics; there are various treatments but no cure. Nevro is advancing its application to the FDA for its spinal cord stimulation treatment of PDN with a potential launch later this year. Nevro is guiding for a...
Nevro Announces Publication Of Landmark SENZA-PDN Clinical Trial Results In JAMA Neurology Level I Randomized Clinical Trial Demonstrates Significantly Improved and Sustained Outcomes with 10 kHz Spinal Cord Stimulation Patients Suffering from Painful Diabetic Neuropathy Exp...
The following slide deck was published by Nevro Corp. in conjunction with their 2020 Q4 earnings call. For further details see: Nevro Corp. 2020 Q4 - Results - Earnings Call Presentation
Nevro Corp (NVRO) Q4 2020 Earnings Conference Call February 24, 2021, 16:30 ET Company Participants Julie Dewey - VP, IR & Corporate Communications Keith Grossman - Chairman, CEO & President Roderick MacLeod - CFO Conference Call Participants Adam Maeder - Piper Sandler & Co. Will...
Image source: The Motley Fool. Nevro Corp (NYSE: NVRO) Q4 2020 Earnings Call Feb 24, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Nevro Corp (NVRO) Q4 2020 Earnings Call Transcript
Nevro (NVRO): Q4 GAAP EPS of -$0.21 beats by $0.13.Revenue of $109.7M (-4.1% Y/Y) beats by $2.27M.Cash, cash equivalents and short-term investments totaled $588M as of December 31, 2020.Press Release For further details see: Nevro EPS beats by $0.13, beats on revenue
Nevro Reports Fourth Quarter and Full Year 2020 Financial Results PR Newswire REDWOOD CITY, Calif. , Feb. 24, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the t...
Nevro (NYSE:NVRO) is scheduled to announce Q4 earnings results on Wednesday, February 24th, after market close.The consensus EPS Estimate is -$0.35 (+20.5% Y/Y) and the consensus Revenue Estimate is $107.43M (-6.1% Y/Y).Over the last 1 year, NVRO has beaten EPS estimates 50% of the time and h...
News, Short Squeeze, Breakout and More Instantly...
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 PR Newswire REDWOOD CITY, Calif. , July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-chan...
Nevro to Present at Truist Securities MedTech Conference PR Newswire REDWOOD CITY, Calif. , June 11 , 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chr...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif. , May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the trea...